Sinead Delany-Moretlwe, MBBCh PhD DTM&H is a Director: Research at Wits RHI and Professor of Global Health and Infectious Diseases at the University of the Witwatersrand, Johannesburg. Her research interests span the intersections between sexual and reproductive health (SRH) and infectious diseases, particularly in adolescent girls and young women (AGYW).
She has worked on several phase III trials of new HIV prevention technologies, including oral, topical and injectable PrEP. She leads the HPTN 084 trial that is currently assessing injectable cabotegravir use in pregnant and lactating women. Her SRH interests include studies to evaluate HPV screening and vaccination approaches for populations living with HIV, as well as trials of new treatments and vaccines for gonorrhoea and other STIs.
She is an advisor to the South African National Department of Health PrEP technical working group and serves on several WHO advisory committees.
